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Despite extensive research on the canonical Wnt signaling pathway, the mechanism by which this
signal downregulates the activity of destruction complexes and inhibits b-catenin degradation re-
mains controversial. In particular, recent attention has focused on two main competing mecha-
nisms—inhibition of phosphorylation and inhibition of ubiquitination. Our combined experimental
and theoretical analysis demonstrates that the disassembly of a fraction of the intracellular destruc-
tion complexes results in the partial inhibition of both b-catenin phosphorylation and ubiquitination.
This inhibition is spatially patterned, consistent with the relocalization of some destruction complexes
to the cellular membrane uponWnt stimulation. Moreover, in contrast to the generally accepted view
that the destruction complex is highly processive, our analysis supports a distributive model, in which
b-catenin can dissociate from the complex between sequential phosphorylation events. Understand-
ing the fundamental mechanism by which Wnt signaling is regulated provides a rational basis for tun-
ing the pathway for scientific and therapeutic purposes.
INTRODUCTION
The canonical Wnt signaling pathway has been the subject of extensive research given its fundamental role
in biological processes ranging from development to controlling stem cell fate and because of the associ-
ation of abnormal Wnt signaling with cancers (Azzolin et al., 2014; Bilic et al., 2007; Clevers, 2006; Cong
et al., 2004; Hernandez et al., 2012; Kim et al., 2013; Li et al., 2012; Nelson and Nusse, 2004; Nusse and
Clevers, 2017; Nusse and Varmus, 2012; Peifer and Polakis, 2000). In the absence of a Wnt signal, b-catenin
binds to the destruction complex and is sequentially phosphorylated by CK1 (at Ser45) and GSK3 (at Ser33/
37/Thr41), then ubiquitinated by the b-TrCP ubiquitin E3 ligase complex, and finally degraded by the pro-
teasome (Nusse and Clevers, 2017). The continuous synthesis and degradation of b-catenin collectively
result in a low steady-state level of this Wnt effector (Hernandez et al., 2012). The canonical Wnt signaling
pathway is activated by the binding of Wnt to its cellular receptors Frizzled (Fzd) and LRP5/6 (Cong et al.,
2004; Nusse and Clevers, 2017). Wnt stimulation inhibits the destruction complex-mediated degradation of
b-catenin by a mechanism that remains controversial, but results in an increase in the cytosolic concentra-
tion of b-catenin. The accumulated b-catenin translocates to the nucleus and, together with the T-cell factor
(TCF) family of transcription factors, activates transcription (Cong et al., 2004).
Although numerous mechanisms have been proposed to explain the Wnt-mediated increase in levels of
b-catenin, recent attention has focused on two main competing mechanisms—inhibition of ubiquitination
and inhibition of phosphorylation (Figure 1A) (Azzolin et al., 2014; Hernandez et al., 2012; Kim et al., 2013;
Li et al., 2012). Li et al. (2012) observed that the cytosolic accumulation of b-catenin was detectable as
early as 30 min following Wnt treatment. They concluded that this initial activation of the Wnt pathway
could not be caused by Axin1 degradation, since significant degradation of Axin1 was not observed until
4 hr post-Wnt stimulation (Li et al., 2012). To elucidate the mechanism of Wnt activation, Li et al. (2012)
immunoprecipitated Axin1 and thus pulled down the other proteins associated with the destruction
complex. Their experiments suggested that the destruction complex remained intact following Wnt
stimulation. They reported that the concentrations of CK1-phosphorylated b-catenin (CK1-p-b-cat) and
GSK3-phosphorylated b-catenin (GSK3-p-b-cat) associated with Axin1 increased, whereas the amount of
ubiquitinated GSK3-p-b-cat associated with Axin1 decreased after Wnt stimulation. Li et al. (2012)
concluded that Wnt stimulation led to a temporary inactivation-by-saturation of the destruction complex
with GSK3-p-b-cat. Azzolin et al. (2014) also suggested a primary role for the inhibition of ubiquitination.
They reported that the Hippo transducer proteins YAP/TAZ formed a part of the destruction complex andiScience 6, 13–21, August 31, 2018 ª 2018 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Characterizing b-Catenin Dynamics in Response to Wnt-3A Stimulation
(A) Schematic showing two models that have been proposed to explain Wnt-induced increases in levels of b-catenin.
Model 1 (top) suggests that the inhibition of phosphorylation by CK1 and/or GSK3 causes b-catenin to accumulate in the
cell, whereas Model 2 (bottom) is based on the inhibition of ubiquitination.
(B–D) Characterization of changes in the concentration of (B) non-membrane-associated b-catenin, (C) whole-cell CK1-
phosphorylated-b-catenin, and (D) GSK3-phosphorylated-b-catenin with time upon Wnt stimulation through
immunoblotting. Plots show mean G1 SD (n = 3 replicates).
(E) Characterization of concentrations of newly synthesized azidohomoalanine-tagged proteins before () and after (+)
Wnt stimulation after pull down with streptavidin-agarose beads (Strep) or agarose beads (control). Input lanes
14 iScience 6, 13–21, August 31, 2018
Figure 1. Continued
correspond to samples before pull down with streptavidin-agarose beads and therefore represent total protein, not
newly synthesized AHA-tagged proteins. The input lanes were imaged separately.
(F) Characterization of changes in protein-protein interactions upon Wnt stimulation via co-immunoprecipitation (IP)
using an anti-Axin1 antibody.
See also Figure S1.were essential for the docking of the b-TrCP ubiquitin E3 ligase. They suggested that Wnt stimulation
caused YAP/TAZ to be released from the destruction complex, preventing the docking of the E3 ligase
and thus inhibiting ubiquitination.
In contrast, Hernandez et al. (2012) suggested a primary role for the inhibition of the CK1 and GSK3
phosphorylation steps. They stimulated mammalian cells with Wnt-3a and measured time-dependent
changes in the concentrations of total and phosphorylated b-catenin. The total cytosolic b-catenin con-
centration initially increased with time and then reached a higher steady-state level, whereas the concen-
tration of GSK3-p-b-cat decreased initially but subsequently recovered. Moreover, the maximum in the
rate of accumulation of total b-catenin coincided in time with the minimum in the concentration of
GSK3-p-b-cat. Kim et al. (2013) also reported that the ratio of the concentration of GSK3-p-b-cat to
that of total b-catenin decreased significantly upon Wnt stimulation and never recovered over time
and suggested that this decrease indicated a key role for the inhibition of phosphorylation. Hernandez
et al. (2012) reasoned that these dynamics were inconsistent with inhibition at a step downstream of
phosphorylation (e.g., ubiquitination) and also noted that their results were consistent with the inhibition
of phosphorylation due to the disassembly of the destruction complex. Moreover, they argued that if
Wnt caused complete inhibition of destruction complex activity by its saturation, then the degradation
flux would not recover to its original level, resulting in an uncontrolled accumulation of b-catenin.
Thus, a mechanistic model of Wnt signaling must also explain how b-catenin is maintained at an elevated
steady-state level upon Wnt stimulation and what prevents it from accumulating indefinitely (Hernandez
et al., 2012).RESULTS AND DISCUSSION
To clarify this issue, we conducted experiments using HEK293T cells, which have been used in many of the
seminal mechanistic investigations of Wnt signaling (Azzolin et al., 2014; Hernandez et al., 2012; Kim et al.,
2013; Li et al., 2012). We also stress that for the reasons noted by Li et al (Li et al., 2012), we did not use
overexpression analyses and instead characterized endogenous destruction complexes.
We stimulated cultured HEK293T cells with Wnt-3a and first monitored changes in the levels of total
b-catenin over time. A significant amount of b-catenin in these cells is reported to remain associated
with membrane-bound E-cadherin complexes, a highly stable pool not involved in canonical Wnt
signaling (Li et al., 2012). As a result, in keeping with prior studies, we removed the membrane-asso-
ciated b-catenin fraction by incubating whole-cell lysates with concanavalin A-Sepharose 4B beads
(Hernandez et al., 2012) and monitored changes in the level of free (cytoplasmic and nuclear) b-catenin
over time (Figures 1B and S1). Consistent with the results of Hernandez et al. (2012), we observed that
the concentration of total b-catenin increased 15 min after Wnt stimulation and reached an elevated
steady-state concentration in approximately 2 hr (Figure 1B). Since the rate of synthesis of b-catenin
does not change following Wnt stimulation (Hernandez et al., 2012), the observed accumulation of
b-catenin suggests that its rate of degradation must initially decrease. However, 2 hr after Wnt stim-
ulation, the rate of b-catenin degradation must recover to its original value to offset synthesis and
thereby help maintain the new, elevated steady-state concentration of b-catenin. We also monitored
changes in the levels of CK1-p-b-catenin in whole-cell lysates upon Wnt stimulation. Levels of CK1-
p-b-catenin increased with time and also attained a higher steady-state value approximately 2 hr after
Wnt stimulation (Figure 1C).
We next measured the changes in the levels of GSK3-p-b-cat in whole-cell lysates. We found that this level
decreased initially uponWnt stimulation and then recovered, reaching a steady state after 2 hr (Figure 1D).
This observation is consistent with the inhibition of phosphorylation being responsible for the inhibition of
b-catenin degradation, but is inconsistent with inhibition solely occurring downstream of phosphorylation
(e.g., in the ubiquitination step). That is, as noted by Hernandez et al. (2012), if inhibition were to occuriScience 6, 13–21, August 31, 2018 15
downstream of phosphorylation, then GSK3-p-b-cat would continue to accumulate, which would in turn
restore the degradation flux at a higher steady-state level of this species.
Next, we compared the GSK3 phosphorylation of newly synthesized b-catenin with and without Wnt stim-
ulation using bioorthogonal noncanonical amino acid tagging (BONCAT) (Dieterich et al., 2007). In
BONCAT, we tagged the newly synthesized proteins with L-azidohomoalanine, a non-canonical amino
acid that contains an azidemoiety. Using azide-alkyne ‘‘click’’ cycloaddition, the newly synthesized proteins
can then be selectively labeled with biotin and pulled down using streptavidin beads (Debets et al., 2010).
As seen in Figure 1E, newly synthesized b-catenin was GSK3-phosphorylated even after Wnt addition, indi-
cating that some destruction complex activity was retained even after Wnt stimulation. The amount of
newly synthesized GSK3-p-b-cat was, however, lower in the presence of Wnt than in its absence (Figure 1E),
consistent with the partial inhibition of b-catenin phosphorylation uponWnt stimulation. We next sought to
understand the reason for this partial inhibition. It is well known that the binding of Wnt to its cellular re-
ceptors results in the relocalization of some destruction complexes to the cellular membrane (Bilic et al.,
2007; Hendriksen et al., 2008; Li et al., 2012). Indeed, we immunoprecipitated Axin1 from whole-cell lysates
and confirmed that LRP6 co-immunoprecipitated with Axin1 upon Wnt stimulation (Figure 1F). We hypoth-
esized that the partial relocalization of destruction complexes to the cellular membrane may be respon-
sible for the partial loss of destruction complex activity upon Wnt stimulation.
To further probe the mechanism of phosphorylation inhibition, we monitored changes in the levels of non-
membrane-associated GSK3-p-b-cat and CK1-p-b-cat (i.e., the cytoplasmic and nuclear fraction) following
Wnt stimulation (Figures 2A and S2). Importantly, the similarity in the levels of non-membrane-associated
and whole-cell GSK3-p-b-cat at different time points afterWnt stimulation (Figure 2B) indicates that most of
the GSK3-p-b-cat is not membrane associated. Similarly, the data in Figure 2B indicate that most CK1-p-
b-cat is also not membrane associated. These results suggest that relocalization of destruction complexes
to the membrane results in inhibition of their phosphorylation activity, with residual activity after Wnt stim-
ulation primarily coming from non-membrane-associated destruction complexes.
Next, to probe the mechanism responsible for inhibition, we immunoprecipitated adenomatous polyposis
coli (APC) and measured the changes in concentrations of Axin1 and GSK3-p-b-catenin being pulled down
along with APC. We chose to immunoprecipitate APC in light of recent reports that APC levels are signif-
icantly lower than Axin1 levels in HEK293T cells (Kitazawa et al., 2017; Tan et al., 2012). We found that there
was a significant decrease in Axin1-APC interactions upon Wnt stimulation, consistent with a partial disas-
sembly of destruction complexes (Figures 2C and 2D). Valvezan et al. (2012) observed a similar decrease in
Axin1-APC interactions in L cells uponWnt stimulation. We also observed an initial decrease in the concen-
tration of co-immunoprecipitated GSK3-p-b-cat (Figure 2C). These results indicate a partial disassembly of
destruction complexes upon Wnt stimulation, resulting in an initial decrease in the rate of GSK3 phosphor-
ylation and degradation of b-catenin. Levels of co-immunoprecipitated GSK3-p-b-cat had recovered sub-
stantially by 1.5 hr (Figure 2), consistent with b-catenin levels approaching a new steady state.
Collectively, the results from Figures 1 and 2 indicate that upon Wnt signaling, a fraction of the destruction
complexes partitions to the membrane, which inhibits their activity and leads to the inhibition of b-catenin
phosphorylation. The fraction of the destruction complexes in the cytosol, however, remains structurally
intact and active. The decrease in the total number of active destruction complexes results in an initial
decrease in the rate of b-catenin degradation and thus an increase in the intracellular concentration of
b-catenin. Mass action then causes an increase in the rate of b-catenin phosphorylation by the remaining,
active destruction complexes. At the new steady state followingWnt stimulation, the rate of degradation of
b-catenin would once again equal its rate of synthesis, and the flux through the destruction complexes
would be expected to return to its original value.
Figure 3A depicts the sequence of intracellular b-catenin modifications. The rate of phosphorylation by
CK1 is governed byMichaelis-Menten kinetics, and for low substrate concentrations relative to theMichae-
lis constant (KM1), it is given by (kcat1/KM1)[DC][B0], where kcat1 is the catalytic rate of CK1a on the destruction
complex, [DC] is the destruction complex concentration, and [B0] is the concentration of unphosphorylated
b-catenin (Hernandez et al., 2012). In Figure 3A, the rate constant k1=(kcat1/KM1)[DC] (Hernandez et al.,
2012). When [DC] decreases in response to Wnt stimulation, then an increase in [B0] would be required
for the rate of CK1 phosphorylation, (kcat1/KM1)[DC][B0], to recover (Figure 1B).16 iScience 6, 13–21, August 31, 2018
Figure 2. Characterization of Destruction Complex Components upon Wnt Stimulation
(A) Characterization of changes in concentration of non-membrane-associated GSK3-phosphorylated-b-catenin (top) and
CK1-phosphorylated-b-catenin (bottom) with time upon Wnt stimulation through immunoblotting. Plots show meanG1
SD (n = 3 replicates).
(B) Comparison of whole-cell (blue) and non-membrane associated (orange) concentrations of GSK3-phosphorylated-
b-catenin (left) and CK1-phosphorylated-b-catenin (right). Plots show mean G1 SD (n = 3 replicates).
(C) Monitoring changes in interactions of various proteins with APC upon Wnt signaling via co-immunoprecipitation (IP)
using an anti-APC antibody.
(D) Quantifying changes in Axin1-APC interactions upon Wnt stimulation. Plot shows mean G1 SD (n = 5 replicates),
***p < 0.001 by a two-tailed t test.
See also Figure S2.We next used our results to analyze whether the destruction complex activity was processive or distributive.
The generally accepted view is that the destruction complex is processive, with b-catenin undergoing a se-
ries of phosphorylations before being released from the complex. Our results—suggesting inhibition of
phosphorylation due to partial disassembly that causes a decrease in the number of active destruction
complexes—are inconsistent with this view. As explained by Hernandez et al. (2012), in the ‘‘processive’’iScience 6, 13–21, August 31, 2018 17
Figure 3. Modeling b-Catenin Dynamics in Response to Wnt Stimulation
(A) Cartoon showing sequential enzymatic modifications of b-catenin.
(B–D) Comparison of results from numerical integration of rate equations with experimental data for changes in concentrations of (B) total b-catenin, (C)
GSK3-p-b-cat, and (D) CK1-p-b-cat. Values of the rate constants (k1, k2, and k3) were each assumed to decrease to 0.44 times their original value, to reflect the
decrease in the number of active destruction complexes.
(E–G) Comparison of results from numerical integration of rate equations with experimental data for changes in concentrations of GSK3-p-b-cat for a
decrease in the value of (E) only k3, (F) only k2, and (G) k1 and k2, but not k3. Experimental data in plots (B–G) show mean G1 SD (n = 3 replicates).
See also Figure S3.case, CK1-p-b-cat would remain bound to the destruction complex before its GSK3 phosphorylation, and
the rate of GSK3 phosphorylation would be (k2)[CK1-p-b-cat]; the rate constant for GSK3 phosphorylation,
k2 (Figure 3A), would then be independent of the destruction complex concentration and depend only on
the intrinsic catalytic activity of GSK3 in the complex (k2 = kcat2). The concentration of CK1-p-b-cat at the
new steady state should therefore return to its original value, so that the rate of GSK3 phosphorylation
(k2*[CK1-p-b-cat]) also recovers. In contrast, we see a significant (5-fold) increase in the concentration
of CK1-p-b-catenin upon Wnt stimulation (Figure 1D), similar to the significant increase in concentration
of total b-catenin. This significant increase is inconsistent with a processive model and supports a distrib-
utive model for destruction complex activity, with the increase in CK1-p-b-cat concentration being neces-
sary to compensate for the decrease in [DC]. CK1-p-b-cat would therefore be present in both free and
destruction-complex-bound states.
As seen in Figure 1C, the concentration of GSK3-p-b-cat at the new steady state (followingWnt stimulation)
is also greater than its initial value. Our co-immunoprecipitation results confirm that levels of destruction-
complex-bound GSK3-p-b-cat recover to their original steady-state value upon Wnt stimulation. Collec-
tively, these results suggest that GSK3-p-b-cat is also present in both free and destruction-complex-bound
states. Moreover, these results are consistent with ubiquitination occurring primarily in an intact destruc-
tion complex as suggested by Li et al. (2012). An increase in the total concentration of GSK3-p-b-cat would
be required if ubiquitination were occurring primarily in the destruction complex, to compensate for the
decrease in the number of active destruction complexes uponWnt stimulation. In contrast, if ubiquitination
were occurring primarily outside the destruction complex, we would not expect to see an increase in total
levels of GSK3-p-b-cat at the new steady state.18 iScience 6, 13–21, August 31, 2018
Figure 4. Proposed Mechanism for Wnt Signaling
(Left) In the absence of Wnt, all destruction complexes target cytosolic b-catenin for degradation. (Right) Wnt stimulation causes the disassembly of a
fraction of the intracellular destruction complexes, inhibiting their ability to phosphorylate and ubiquitinate cytosolic b-catenin. Levels of free b-catenin
increase until mass action results in a recovery of the rate of degradation of b-catenin by the active destruction complexes.We used our results to predict b-catenin dynamics in response to Wnt signaling (Figures 3B–3D and Sup-
plemental Information). In our proposed distributive model, the response to a Wnt signal is caused primar-
ily by a decrease in the number of active destruction complexes, which causes a decrease in magnitudes of
the rate constants for phosphorylation and ubiquitination—k1, k2, and k3 (Figure 3A). The lines in Figures
3B–3D represent b-catenin concentrations obtained by numerical integration of the dynamical equations
(see Supplemental Information, equations S1–S4) with the value of each of the rate constants k1, k2, and k3
being decreased to 0.44 times their value before Wnt stimulation. The choice of 0.44 was guided by exper-
imental data. The average Axin1/APC ratio uponWnt stimulation ranged from ca. 0.39 to 0.5 times its value
before Wnt stimulation (Figure 2D), and 0.44 lies in this range and is close to the average of these two
values. As seen in Figures 3B–3D, the predicted changes in steady-state concentrations and the dynamical
behaviors match the experimental results. In contrast, predictions based on inhibition of only ubiquitina-
tion (Figure 3E) or only phosphorylation (Figures 3F and 3G) do not explain the experimental results for
b-catenin dynamics. If only ubiquitination is inhibited, results obtained by numerical integration of the
dynamical equations do not show a dip in the concentration of GSK3-p-b-cat (Figure 3E). If only phosphor-
ylation is inhibited, but not ubiquitination (Figures 3F and 3G), then GSK3-p-b-cat levels at the new steady
state would recover to their initial value, but not exceed it, in contrast to experimental results. We note that
whereas our experimental data are most consistent with a mechanism based on the inhibition of both phos-
phorylation and ubiquitination (Figures 3 and S3), our simulations do not perfectly match the experimental
data for recovery of GSK3-p-b-cat concentrations. This difference could be due to factors not accounted for
in our simple model. For instance, the inhibition could occur with a slight lag, and at different rates in
different cells, due to heterogeneity in the time taken for Wnt to diffuse and bind to receptors on different
cells and in the time required for complex disassembly.
In summation, our results support the following mechanistic model for Wnt signaling (Figure 4). Following
Wnt stimulation, some of the destruction complexes relocate to the membrane, where they are associated
with LRP6, and this subsequently leads to the dissociation of APC from the destruction complexes and the
inhibition of GSK3 phosphorylation of b-catenin. The remaining destruction complexes remain intact and
active in the cytoplasm. However, the initial decrease in the number of active destruction complexes results
in an initial decrease in the rate of degradation of b-catenin. Consequently, free b-catenin is able toiScience 6, 13–21, August 31, 2018 19
accumulate, until mass action results in an increase in the levels of destruction-complex-bound GSK3-p-
b-cat and a recovery of the rate of degradation of b-catenin, but at an elevated steady-state level of b-cat-
enin. We note that although it is possible that there are also free kinases in the cell, numerous published
reports have confirmed a primary role for destruction complexes in mediating b-catenin phosphorylation
and degradation (Li et al., 2012). Destruction complex-mediated degradation of b-catenin may in fact facil-
itate the regulation of intracellular levels of b-catenin in response to external signals, allowing the binding
of an ‘‘external’’ Wnt ligand to induce the relocation of destruction complexes to the membrane, their
disassembly, and a resulting increase in levels of b-catenin. Recent reports have suggested a role for a
spatially localized Wnt signal in asymmetric stem cell division (Habib et al., 2013). It is intriguing that the
spatial patterning of destruction complex activity is itself central to the core Wnt signal transduction mech-
anism. Understanding this fundamental mechanism provides a rational basis for tuning the pathway for sci-
entific and therapeutic purposes (Kahn, 2014; Nusse and Clevers, 2017).
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Transparent Methods and three figures and can be found with this
article online at https://doi.org/10.1016/j.isci.2018.07.007.
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Supplementary Information: 
Transparent Methods: 
Mammalian Cell Culture and treatment with Wnt-3A and MG132 
Human embryonic kidney (HEK293T) cells were purchased from the American Type Culture 
Collection (ATCC CRL-11268) and cultured in Dulbecco’s Modified Eagle Medium (High-
glucose DMEM; Gibco 11995065) supplemented with 10% HI-FBS (Heat-Inactivated Fetal 
Bovine Serum; Gibco 10438018) and 1% penicillin-streptomycin (Gibco) (hereon referred to as 
D-10 media) in a humidified incubator at 37C with 5% CO2. Cultured mammalian cells were 
treated with recombinant human Wnt-3A (R&D Systems; 5036-WN) at a final concentration of 
750-1000 ng/ml for the indicated time periods. Proteasomal inhibitor MG132 (Sigma-Aldrich; 
M7449) treatment was done at a working concentration of 20 M for the time periods mentioned 
in the article.  
Antibodies 
The following antibodies were used for immunoblotting and immunoprecipitation; anti--catenin 
(BD Transduction Laboratories; #610153), anti-phospho--catenin antibody (Ser33/37/Thr41) 
(Cell Signaling Technology; #9561), anti-phospho--catenin antibody (Ser45) (Cell Signaling 
Technology; #9564), anti-APC (Cell signaling Technology, #2504), anti-APC (Abcam; 
#ab15270), anti-Axin1 (Cell Signaling Technology; #2087), monoclonal rabbit IgG isotype 
control (Abcam; #ab172730), anti-LRP6 (C5C7) antibody (Cell Signaling Technology; #2560), 
anti--tubulin (Abcam; #ab52866), anti-Histone H3 (Abcam; #ab1791), anti-biotin (Abcam; 
#ab53494) and anti-GAPDH (Abcam; #ab8245). 
 
Harvesting cells and preparation of whole-cell lysates and cytoplasmic and nuclear extracts 
for time series experiments 
HEK293T cells were cultured in 6-well tissue culture plates (Corning) at an initial concentration 
of 1.5 million cells per well and allowed to grow 80-90% confluent after approximately 36-48 h. 
After experimentation, the cells were washed in ice-cold DPBS (Corning) twice and lysed in a 
lysis buffer of DPBS containing 0.5% digitonin (pH 7.5) (Kim et al.). The cells were incubated on 
ice for 30-45 min for complete lysis and then harvested using cell scrapers. The residual debris in 
the lysate was spun down after centrifugation at 13,000 g for 15 min. The supernatant was used as 
the whole-cell lysate for further analysis.  
To obtain the cytoplasmic and nuclear extract of HEK293T cells, the above supernatant was 
incubated with Concanavalin A-Sepharose 4B (GE Healthcare) beads for 60 min at 4C. After 
incubation, the beads were spun down at 3000g for 5 mins. The cytoplasmic and nuclear fractions 
of the lysates were in the supernatant and the membrane-associated proteins were bound to the 
Concanavalin A beads. The whole-cell lysates and cytoplasmic and nuclear fractions of the lysates 
were denatured after the addition of LDS Sampling Buffer (Thermo Scientific) at 100C for 10-15 
mins and then processed for immunoblotting (western blots). 
BONCAT and detection of newly synthesized protein 
Methionine-free, cystine-free Dulbecco’s Modified Eagle Medium (DMEM) containing 4 mM of 
L-Azidohomoalanine or L-AHA (Anaspec; #AS-63669) was used for the unnatural amino acid 
tagging experiments. HEK293T cells were cultured in 15 cm tissue culture dishes (Corning) at an 
initial concentration of 15 million cells per dish for 36-48 hours in D-10 media. After the cells 
were treated with Wnt-3A for 0.5 hours, the D-10 media was removed and the cells were washed 
twice with DPBS followed by one wash with methionine-free, cystine-free Dulbecco’s Modified 
Eagle Medium (DMEM). The cells then treated with L-AHA containing DMEM (containing 20 
M MG-132 and Wnt-3A as mentioned in the article) for 2.5 hours. The cells were then washed 
twice with ice-cold DPBS (Corning) and lysed using 2% SDS in DPBS containing phosphatase 
(Sigma-Aldrich) and protease inhibitor (Thermo Scientific) cocktails at concentrations prescribed 
by the manufacturer(s). The lysates were subsequently denatured by boiling at 100C for 15 mins. 
To reduce the viscosity of the protein lysates, the samples were treated with benzonase nuclease 
(Sigma Aldrich; #E1014) at 37C for 30 mins with constant mixing. 10 mg of total processed 
lysates were reacted with 150 M DBCO-sulfo-biotin for 3-5 hours at room temperature. The 
reaction was quenched with excess L-AHA and passed through PD-10 (GE Healthcare) desalting 
columns to remove unreacted DBCO-sulfo-biotin and other low molecular weight compounds. 
The biotin-tagged proteins were then quantified using a semi-quantitative dot-blot (as per Dieterich 
et al.). The biotin-tagged proteins were finally extracted by incubating with Streptavidin-agarose 
beads (Thermo Scientific) for 2 hours at room temperature. Streptavidin beads were then washed 
with 2% SDS in PBS 5-6 times to remove the non-biotin tagged proteins. The protein mixture was 
then denatured using the LDS Sample Loading Buffer (Thermo Scientific) at 100C for 10-15 min 
and loaded onto 4-12% Bis-Tris Gels for further analysis. 
Co-Immunoprecipitation (Co-IP) 
HEK293T cells were cultured in 15-cm tissue culture dishes (Corning) at an initial concentration 
of 15 million cells per dish and incubated in D-10 media for approximately 36-48 hours till 80% 
confluency. After experimentation, the cells were washed in ice-cold DPBS (Corning) twice and 
lysed in ~2 ml of lysis buffer containing 25 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% NP-40, 1 
mM EDTA, 5% glycerol (for anti-APC IP) or 150 mM NaCl, 30 mM Tris (pH 7.5), 1 mM 
EDTA, 1% Triton X-100, 10% Glycerol (for anti-Axin1 IP). Lysis buffers were supplemented 
with 0.1 mM PMSF, 0.5 mM DTT, phosphatase inhibitor cocktails 2 &3 (at 1:100 dilution) 
(Sigma) and Halt protease inhibitor cocktail (at 1:100 dilution) (Thermo Scientific). The cells 
were then incubated on ice for 30-45 mins, harvested and spun down at speeds mentioned earlier. 
After being spun down at 13,000 g for 15 mins, cell lysates were pre-cleared by incubating with 
Rabbit IgG isotype control antibody (Abcam, #ab172730) for 4 hours followed by Pierce Protein 
A Magnetic beads (Thermo Scientific) for 2 hours at 4C. A magnetic rack (MagnaRack; Thermo 
Scientific) was then used to separate out the magnetic beads and the supernatant was then 
incubated overnight with the appropriate antibody at 4C with constant mixing. The lysate was 
then incubated in Protein A magnetic beads for 2 hours at 4C with constant mixing. The magnetic 
beads were then separated using the MagnaRack, washed 5 times with TBS containing 0.1% 
Tween-20 and then by 1x TBS. The beads were then denatured in 2x LDS Sampling Buffer with 
2-mercaptoethanol by heating at 95-100C for 15 mins. The magnetic beads were again separated 
and the supernatant containing the immunoprecipitated proteins were analyzed using 
immunoblotting. 
SDS-PAGE Gel Electrophoresis and Immunoblotting 
 Proteins in the lysates were resolved using SDS-PAGE in 3-8% Tris-Acetate (for detecting APC) 
and 4-12% Bis-Tris Polyacrylamide gels (for all other proteins) in OWL P8DS (Thermo 
Scientific). The proteins were then transferred to a nitrocellulose membrane using electrophoretic 
transfer in the Trans-Blot Turbo Transfer System (Bio-Rad). 
  For immunoblotting, the membrane was blocked in a blocking buffer (TBS, 0.1% Tween-20, 5% 
non-fat dry milk or BSA; per antibody manufacturer’s recommendation) for 1 hour at room 
temperature. The membrane was then incubated overnight at 4C in primary antibody diluted in 
5% BSA in TBST (TBS, 0.1% Tween-20). The dilution used for different antibodies was 
optimized for individual applications, using the manufacturer’s recommendation as the starting 
point. After the primary antibody incubation, the membrane was washed three times with TBST 
for 5 min each and then incubated in secondary antibody diluted in the blocking buffer for 1 hour 
at room temperature. For total -catenin detection, an HRP-conjugated anti-mouse antibody 
(Jackson Immunoresearch) was used at a dilution of 1:10000. In all other cases, an HRP-
conjugated anti-rabbit antibody (Thermo Scientific) was used at a dilution of 1:3000-1:5000. The 
protein bands in the membrane were then detected in a ChemiDoc MP Imaging system (Bio-Rad) 
using the SuperSignal West Femto Maximum Sensitivity Substrate. Quantitation of the protein 
concentration from the detected protein bands was carried out by using the analysis tools provided 
in the Image Lab Software (Bio-Rad) and validated using the ImageJ software in the previously 
ascertained linear dynamic range of concentrations for respective proteins. 
Modeling -catenin dynamics 
B0, B1, B2, and B3 represent unphosphorylated -catenin, CK1-phosphorylated -catenin, GSK3-
phosphorylated -catenin, and ubiquitylated -catenin, respectively(Hernandez et al., 2012) 
respectively. S represent the rate of synthesis of -catenin, [Bi] denote concentrations (i = 0, 1, 2, 
3), and kdeg and kj,, (j = ±1, ±2, ±3) denote rate constants.  The phosphorylation and degradation 
of β-catenin is modeled using the following dynamical equations (Hernandez et al., 2012): 
ௗሾ஻బሿ
ௗ௧ ൌ ܵ െ ݇ଵሾܤ଴ሿ ൅ ݇ିଵሾܤଵሿ                                            (S1) ௗሾ஻భሿ
ௗ௧ ൌ ݇ଵሾܤ଴ሿ െ ሺ݇ଶ ൅ ݇ିଵሻሾܤଵሿ ൅ ݇ିଶሾܤଶሿ    (S2) ௗሾ஻మሿ
ௗ௧ ൌ ݇ଶሾܤଵሿ െ ሺ݇ଷ ൅ ݇ିଶሻሾܤଶሿ +	݇ିଷሾܤଷሿ   (S3) ௗሾ஻యሿ
ௗ௧ ൌ ݇ଷܤଶ െ ሺ݇ௗ௘௚ ൅ ݇ିଷሻሾܤଷሿ    (S4) 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S1, related to Fig. 1. Characterization of protein fractions after pull-down using 
Concanavalin A-Sepharose 4B beads at different time points following Wnt-3A stimulation. 
Within each time point, Lane 1 shows the protein in whole cell lysates, Lane 2 shows the flow-
through after treatment with Concanavalin A-Sepharose 4B beads, and Lane 3 shows proteins 
eluted from the beads.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2, related to Fig. 2. Characterization of protein fractions after pull-down using 
Concanavalin A-Sepharose 4B beads at different time points following Wnt-3A stimulation. 
Within each time point, Lane 1 shows the protein in whole cell lysates, Lane 2 shows the flow-
through after treatment with Concanavalin A-Sepharose 4B beads, and Lane 3 shows proteins 
eluted from the beads.  
 
Figure S3, related to Fig. 3. Ubiquitinated GSK3-p--catenin levels in presence of Wnt 
signaling. Lane 1 and Lane 2 shows ubiquitinated GSK3-p--catenin levels in absence and 
presence of Wnt-3A respectively. The protein loading in Lane 3 was adjusted to compare 
ubiquitination levels for the same amount of GSK3-p--catenin in absence and presence of Wnt-
3A respectively. 
 
